151 related articles for article (PubMed ID: 26629514)
1. MERS Vaccine Candidate Offers Promise, but Questions Remain.
Menachery VD
EBioMedicine; 2015 Oct; 2(10):1292-3. PubMed ID: 26629514
[No Abstract] [Full Text] [Related]
2. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
3. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.
Tai W; Zhao G; Sun S; Guo Y; Wang Y; Tao X; Tseng CK; Li F; Jiang S; Du L; Zhou Y
Virology; 2016 Dec; 499():375-382. PubMed ID: 27750111
[TBL] [Abstract][Full Text] [Related]
4. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of candidate vaccine approaches for MERS-CoV.
Wang L; Shi W; Joyce MG; Modjarrad K; Zhang Y; Leung K; Lees CR; Zhou T; Yassine HM; Kanekiyo M; Yang ZY; Chen X; Becker MM; Freeman M; Vogel L; Johnson JC; Olinger G; Todd JP; Bagci U; Solomon J; Mollura DJ; Hensley L; Jahrling P; Denison MR; Rao SS; Subbarao K; Kwong PD; Mascola JR; Kong WP; Graham BS
Nat Commun; 2015 Jul; 6():7712. PubMed ID: 26218507
[TBL] [Abstract][Full Text] [Related]
6. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
[TBL] [Abstract][Full Text] [Related]
7. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism.
Schindewolf C; Menachery VD
Viruses; 2019 Jan; 11(1):. PubMed ID: 30658390
[TBL] [Abstract][Full Text] [Related]
8. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.
Tang XC; Agnihothram SS; Jiao Y; Stanhope J; Graham RL; Peterson EC; Avnir Y; Tallarico AS; Sheehan J; Zhu Q; Baric RS; Marasco WA
Proc Natl Acad Sci U S A; 2014 May; 111(19):E2018-26. PubMed ID: 24778221
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.
Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM
Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568
[TBL] [Abstract][Full Text] [Related]
10. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
[TBL] [Abstract][Full Text] [Related]
11. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.
Ma C; Wang L; Tao X; Zhang N; Yang Y; Tseng CK; Li F; Zhou Y; Jiang S; Du L
Vaccine; 2014 Oct; 32(46):6170-6176. PubMed ID: 25240756
[TBL] [Abstract][Full Text] [Related]
12. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
Okba NMA; Widjaja I; van Dieren B; Aebischer A; van Amerongen G; de Waal L; Stittelaar KJ; Schipper D; Martina B; van den Brand JMA; Beer M; Bosch BJ; Haagmans BL
Emerg Microbes Infect; 2020 Dec; 9(1):1080-1091. PubMed ID: 32471334
[TBL] [Abstract][Full Text] [Related]
13. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
14. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
15. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection.
Jia W; Channappanavar R; Zhang C; Li M; Zhou H; Zhang S; Zhou P; Xu J; Shan S; Shi X; Wang X; Zhao J; Zhou D; Perlman S; Zhang L
Emerg Microbes Infect; 2019; 8(1):760-772. PubMed ID: 31130102
[TBL] [Abstract][Full Text] [Related]
16. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
[TBL] [Abstract][Full Text] [Related]
17. MERS-CoV spike protein: Targets for vaccines and therapeutics.
Wang Q; Wong G; Lu G; Yan J; Gao GF
Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
[TBL] [Abstract][Full Text] [Related]
18. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
Kim MH; Kim HJ; Chang J
PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
[TBL] [Abstract][Full Text] [Related]
19. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.
Alharbi NK; Padron-Regalado E; Thompson CP; Kupke A; Wells D; Sloan MA; Grehan K; Temperton N; Lambe T; Warimwe G; Becker S; Hill AVS; Gilbert SC
Vaccine; 2017 Jun; 35(30):3780-3788. PubMed ID: 28579232
[TBL] [Abstract][Full Text] [Related]
20. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.
Lan J; Deng Y; Song J; Huang B; Wang W; Tan W
Virol Sin; 2018 Oct; 33(5):453-455. PubMed ID: 30374826
[No Abstract] [Full Text] [Related]
[Next] [New Search]